The Ministry of Health and Prevention has issued an alert on the consumption of four pharmaceutical products that are used primarily in the treatment of respiratory, neurological, contagious infection and thyroid ailments because of the possibility of microbial contamination.
The ministry has issued warnings against certain products like Neuroveen, which is used for neuralgia nerve pain, Respitrol that is used for relief from tightness in the chest, Thyroveev, a drug supposed to counter underactive thyroid and Compulsin, used to combat obsessive thoughts.
The advisory was issued by the Ministry to all the medical zones, private and public hospitals, pharmacists and doctors. The advisory also highlighted the fact that these pharmaceutical products are distributed globally through means of retail, wholesale and even online sales.
The advisory was prompted by a warning that was issued by the US FDA and the manufacturer Hellolife, which said that use of the products could actually aggravate the condition, inviting the need for medical intervention.